03May 2023
Xylazine — Medical and Public Health Imperatives

Xylazine — Medical and Public Health Imperatives

The increasing use of xylazine, often combined with other drugs like fentanyl, is a growing health threat in the US. Xylazine is an α2-agonist drug that was initially studied for use as an antihypertensive agent in humans but is now only approved for use as a sedative in veterinary medicine. Centrally acting α2-agonist drugs inhibit the release of norepinephrine and epinephrine, leading to sedation, analgesia, and euphoria. Despite historically being associated with a low risk of illicit use, xylazine use can cause physiological dependence, withdrawal symptoms, and a xylazine-related substance use disorder. Discontinuation without assistance is often not feasible due to the severity of withdrawal symptoms and the uncertainty of effective treatment options.

  • #family health

Like

Save

Share